ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981